The research, published in PLOS Genetics by Jake Colautti, Alexander C. Anderson, Wyatt P. K. Clark, and Lindsey S. Marmont, focuses on a long-standing puzzle in bacterial cell biology: how dividing cells switch on the synthesis of septal peptidoglycan, the new cell wall material that must be forged at exactly the right place and time as a bacterium splits in two. In rod-shaped bacteria such as P. aeruginosa and the better-studied Escherichia coli, this task falls to a pair of enzymes known as FtsW and FtsI. FtsW is a member of the SEDS family of membrane proteins, while FtsI is a class B penicillin-binding protein, and together the FtsWI complex carries out the essential work of polymerizing and cross-linking the peptidoglycan strands at the division septum. Without properly regulated FtsWI activity, the cell cannot complete division and dies.

For years, microbiologists have believed that FtsWI sits in a dormant state until it receives an activating signal from the rest of the divisome, the elaborate protein assembly that assembles at the future site of division. The accepted model describes an allosteric cascade: the late-arriving divisome protein FtsN, considered the final trigger of cytokinesis, transmits its signal through the FtsQ, FtsL, and FtsB proteins, which form a complex known as FtsQLB, and this complex in turn stimulates FtsWI to begin building the septum. Yet the molecular details of this handoff have remained murky, and the picture appears to differ from one bacterial species to another. The new study set out to clarify how this regulatory cascade works in P. aeruginosa, an organism that is both a formidable pathogen and, until recently, less genetically tractable than E. coli.

The team’s strategy exploited a key genetic feature: the gene encoding FtsN, while essential, can be studied through conditional essentiality, meaning the researchers could remove it and then search for mutations elsewhere in the genome that allow cells to survive without it. This approach, often called a suppressor screen, is a powerful way to identify the components of a regulatory pathway. If a mutation in another gene can compensate for the loss of FtsN, that gene very likely participates in the same process. When the researchers deleted ftsN and looked for survivors, they found them, and the compensating mutations mapped to a specific region of the ftsI gene encoding the non-enzymatic pedestal domain of the FtsI protein.

The pedestal domain is a region of FtsI that sits outside the enzyme’s catalytic machinery, and it had not previously been considered a major control point for septal cell wall synthesis. The substitutions the team identified did more than merely rescue the loss of FtsN. The mutant cells also suppressed the toxic effects of activation-defective ftsL alleles, versions of FtsL that dominantly disrupt division when present, and they shortened cell length even in an otherwise normal genetic background. Together, these observations indicate that the pedestal mutations change how FtsWI is regulated, allowing the enzyme complex to escape its dependence on stimulation by both FtsN and the FtsQLB complex. In effect, the mutations rewire the switch that normally holds septal peptidoglycan synthesis in check until the divisome is fully assembled.

To understand where these substitutions sit in three-dimensional space, the researchers mapped them onto the recently determined structure of the P. aeruginosa FtsQLBWI complex. The result was striking: rather than clustering at a single site, the mutations grouped onto distinct surfaces of the pedestal domain. Some variants localized to the interface where FtsI contacts FtsL, consistent with the idea that the FtsQLB complex physically transmits its activating signal to FtsWI through this contact. Others sat on the opposite face of the pedestal, suggesting that this surface engages a different regulatory input, possibly FtsN itself or another partner in the divisome. The pedestal domain, in other words, behaves as an integration point where multiple signals converge to control the timing and magnitude of septal cell wall construction.

The most consequential twist came from a clinical observation. Several of the pedestal substitutions identified in the study had previously been found in clinical isolates of P. aeruginosa showing increased resistance to aztreonam, a monocyclic β-lactam antibiotic that is one of the few options remaining against multidrug-resistant Gram-negative infections. That overlap prompted the team to ask a direct question: do these cell-division regulatory mutations change how susceptible the bacterium is to β-lactam antibiotics, which kill cells by sabotaging cell wall synthesis?

The answer depended on which surface of the pedestal domain was altered. Variants affecting the FtsI-FtsL interface modestly reduced the bacterium’s susceptibility to multiple β-lactam antibiotics, nudging the minimum inhibitory concentrations upward. Far more dramatic was the effect of a variant on the opposite face of the pedestal: this mutation produced striking hypersusceptibility to the same drugs, but only when FtsN was present. In other words, a single amino acid change in a non-enzymatic region of a cell wall synthase could either harden the pathogen against β-lactams or render it exquisitely vulnerable, depending on its position and on the presence of the divisome’s triggering protein.

These results carry two significant implications. First, they establish the FtsI pedestal domain as a central regulatory hub for FtsWI, resolving long-standing uncertainty about how the FtsN-to-FtsQLB-to-FtsWI cascade is wired in P. aeruginosa and demonstrating that the non-enzymatic architecture of a cell wall synthase can govern its activity. Second, and more urgently, they reveal a previously unrecognized relationship between divisome regulation and β-lactam susceptibility. Antibiotic resistance in P. aeruginosa is usually attributed to enzymatic drug destruction, efflux pumps, and reduced permeability, but this work shows that subtle alterations in the regulation of septal peptidoglycan synthesis can also shift the balance between life and death in the presence of β-lactams, and that such alterations already exist in clinical isolates.

The study also suggests new directions for drug discovery and surveillance. If the pedestal domain integrates the signals that unleash septal cell wall synthesis, then molecules that lock the domain into a hypersusceptible state, mimicking the effect of the sensitizing mutation, could potentially restore the potency of β-lactams against resistant strains. Conversely, sequencing efforts that monitor pedestal-domain residues in clinical P. aeruginosa populations might provide early warning of emerging β-lactam tolerance that conventional resistance mechanisms would miss. As the authors note, the work highlights the potential relevance of divisome regulation to β-lactam resistance in the clinic, transforming a fundamental question about bacterial cell biology into a matter of direct medical consequence.

Subject of Research: Regulation of septal peptidoglycan synthesis and its effect on β-lactam antibiotic susceptibility in Pseudomonas aeruginosa

Article Title: Altered regulation of septal peptidoglycan synthesis modulates β-lactam susceptibility in Pseudomonas aeruginosa

Article References: Colautti, J., Anderson, A. C., Clark, W. P. K., & Marmont, L. S. (2026). Altered regulation of septal peptidoglycan synthesis modulates β-lactam susceptibility in Pseudomonas aeruginosa. PLOS Genetics, 22(9), e1012319. https://doi.org/10.1371/journal.pgen.1012319

Image Credits: AI Generated

DOI: 10.1371/journal.pgen.1012319

Keywords: Pseudomonas aeruginosa, cell division, peptidoglycan synthesis, FtsI, FtsN, FtsQLB complex, divisome, beta-lactam antibiotics, aztreonam, antibiotic resistance, SEDS-bPBP synthase, pedestal domain

The experimental organism, Chlorella vulgaris, is a globally distributed unicellular green alga that sits near the base of aquatic food webs. Because it photosynthesizes, grows quickly and responds rapidly to chemical stress, it is one of the standard test organisms used in ecotoxicology to evaluate how contaminants affect primary producers. If algal growth falters, the consequences cascade upward: less energy captured from sunlight means less food for zooplankton, fish and everything that depends on them. That is why the fate of a single microalgal species matters enormously when regulators try to judge whether a chemical in the water is safe.

The researchers focused on two members of the β-lactam family, the most widely prescribed class of antibiotics in human and veterinary medicine. The first was amoxicillin, a penicillin-derivative consumed in enormous quantities worldwide and frequently detected in effluent from hospitals, livestock operations and municipal treatment plants. The second was aztreonam, a monobactam antibiotic prized for its activity against gram-negative bacteria. Both drugs reach surface waters after being excreted by patients or discarded improperly, since unused antibiotics flushed down drains largely pass through conventional wastewater treatment intact. A recent body of literature has flagged improper disposal of unused antibiotics as an overlooked driver of antimicrobial resistance, but the Tianjin team was interested in a different consequence: what these molecules do to organisms that are not their targets.

The second contaminant was silver nanoparticles, engineered particles of metallic silver measuring mere billionths of a meter across. Silver nanoparticles are among the most commercially successful nanomaterials on the planet, embedded in textiles, food packaging, cosmetics, medical devices and water filters because of their potent antibacterial properties. That same potency, however, extends to non-target organisms, and the particles are known to shed silver ions as they age in the environment. Previous studies have documented toxicity of silver nanoparticles to bacteria, algae, fish and invertebrates, yet most regulatory risk assessments still evaluate chemicals one at a time, an approach that grossly underestimates exposure when multiple contaminants co-occur, as they inevitably do in real receiving waters downstream of wastewater outfalls.

The experimental design was straightforward but rigorous. Cultures of Chlorella vulgaris were exposed for 96 hours to each of the three substances individually across a gradient of concentrations, and then to binary combinations of the antibiotics with the silver nanoparticles. Growth inhibition was used as the primary endpoint, summarized by the median effect concentration, the dose that reduces algal growth by half over the exposure period. The ranking that emerged was unambiguous: silver nanoparticles were the most toxic of the three, aztreonam came second, and amoxicillin was the least harmful on its own. In every case, higher exposure concentrations produced progressively greater suppression of algal growth, confirming dose-dependent toxicity for each compound.

The crucial finding came from the cotreatments. When the antibiotics and silver nanoparticles were present together, their combined effect on the algae was synergistic, meaning the observed toxicity exceeded what would be predicted by simply adding the effects of each chemical alone. The nanoparticles did not merely contribute an independent share of damage; they actively magnified the harm caused by the antibiotics, and the antibiotics in turn intensified the damage caused by the nanoparticles. This kind of interaction is precisely what conventional single-substance testing misses, and it suggests that environmental concentrations of these pollutants, even when each falls below a formal toxicity threshold individually, could still endanger photosynthetic organisms in combination.

To understand what the synergy was doing at the cellular level, the team turned to scanning electron microscopy. The images told a stark story. Algae that had been exposed to a single contaminant showed visible but comparatively limited damage to their cell surfaces, while cells subjected to coexposure displayed markedly more severe structural disruption. The cell wall and membrane, the alga’s first lines of defense, appear to be a shared point of attack: β-lactam antibiotics interfere with cell wall integrity in bacteria, and silver nanoparticles are notorious for compromising membranes and generating reactive oxygen species. When both stressors arrive together, the cell’s protective architecture may be weakened from two directions at once, allowing each toxicant to penetrate more deeply and inflict more damage than either could alone.

Oxidative stress is likely a central player in this interaction. Aquatic toxicologists have long observed that antibiotics such as clarithromycin, erythromycin and roxithromycin trigger antioxidant responses in freshwater microalgae, forcing cells to divert resources into defensive enzymes at the expense of growth. Silver nanoparticles act through a complementary mechanism, releasing silver ions that disrupt electron transport and catalyze the formation of superoxide and other reactive oxygen species inside the cell. When both classes of compounds are present, the combined oxidative burden can overwhelm the antioxidant system, damaging photosynthetic machinery and lipids faster than the cell can repair them. The result is the synergy recorded in the growth data: a whole-cell collapse that neither contaminant could achieve independently at the same doses.

To make sense of the many physiological indicators measured across the study, the researchers applied grey correlation analysis, a statistical technique well suited to small datasets with uncertain or incomplete information. The method quantifies how strongly each measured parameter tracks with the overall toxic outcome, helping to identify which physiological responses are the best predictors of harm under combined exposure. By linking growth inhibition, ultrastructural damage and the underlying biochemical indicators within a single analytical framework, the analysis strengthens the mechanistic interpretation of the synergy and offers a template that other laboratories can use to disentangle complex, multi-stressor toxicity.

The wider implications reach well beyond one species of green alga. Antimicrobial resistance researchers have warned for years that antibiotics polluting aquatic environments do not simply disappear; they persist, transform and interact with other contaminants, including the engineered nanomaterials that society is releasing in ever-larger quantities. This study adds a critical ecological dimension to that concern, showing that the coexistence of β-lactam antibiotics and silver nanoparticles in water is not merely a matter of two pollutants sharing space but of chemically interactive stressors whose joint toxicity to primary producers is greater than their parts. The authors argue that their findings contribute substantially to understanding the joint effects of these contaminants on aquatic organisms and provide solid evidence for the ecological risk assessment of their coexistence in natural waters. For regulators, the message is sobering: risk assessments that test chemicals in isolation will systematically understate the threat, and future water-quality standards may need to account explicitly for mixtures of antibiotics and nanomaterials. For the rest of the ecosystem, the study is a reminder that the health of entire food webs can hinge on the microscopic cells that convert sunlight into life, and that those cells are quietly registering the cumulative burden of everything humanity sends downstream.

Subject of Research: Combined toxicity of β-lactam antibiotics and silver nanoparticles to the freshwater microalga Chlorella vulgaris

Article Title: Physiological responses of Chlorella vulgaris upon coexposure to β-lactam antibiotics and Ag NPs

Article References: Lu, X., Zhang, Z., Huang, R., & Ge, Y. (2026). Physiological responses of Chlorella vulgaris upon coexposure to β-lactam antibiotics and Ag NPs. Ecotoxicology, 35(7), Article 163. https://doi.org/10.1007/s10646-026-03150-4

Image Credits: AI Generated

DOI: 10.1007/s10646-026-03150-4

Keywords: silver nanoparticles, β-lactam antibiotics, amoxicillin, aztreonam, Chlorella vulgaris, combined toxicity, synergistic effects, ecotoxicology, freshwater algae, oxidative stress, ecological risk assessment, water pollution